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Abstract
Background: Peroxisome proliferator-activated receptor γ (PPARγ) is a critical gene that regulates the function of
adipocytes. Therefore, studies on the molecular regulation mechanism of PPARγ are important to understand the
function of adipose tissue. Twist 1 is another important functional gene in adipose tissue, and hundreds of genes
are regulated by Twist 1. The aim of this study was to investigate the regulation of Twist 1 and PPARγ expression in
3T3-L1 mature adipocytes.
Methods: We induced differentiation in 3T3-L1 preadipocytes and examined alterations in Twist 1 and PPARγ
expression. We used the PPARγ agonist pioglitazone and the PPARγ antagonist T0070907 to investigate the effect
of PPARγ on Twist 1 expression. In addition, we utilized retroviral interference and overexpression of Twist 1 to
determine the effects of Twist 1 on PPARγ expression.
Results: The expression levels of Twist 1 and PPARγ were induced during differentiation in 3T3-L1 adipocytes.
Application of either a PPARγ agonist (pioglitazone) or antagonist (T0070907) influenced Twist 1 expression, with
up-regulation of Twist 1 under pioglitazone (1 μM, 24 h) and down-regulation of Twist 1 under T0070907 (100 μM,
24 h) exposure. Furthermore, the retroviral interference of Twist 1 decreased the protein and mRNA expression of
PPARγ, while Twist 1 overexpression had the opposite effect.
Conclusions: There was a possible regulatory link between Twist 1 and PPARγ in 3T3-L1 mature adipocytes. This
regulatory link enhanced the regulation of PPARγ and may be a functional mechanism of Twist 1 regulation of
adipocyte physiology and pathology.
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Background
Adipose tissue is one of the most important functional
organs in the human body and plays a critical role in hu-
man health. Adipose dysfunction is closely related to the
occurrence and development of several diseases, includ-
ing obesity, diabetes, insulin resistance and inflammation
[1–3]. A number of genes are involved in the regulation
of adipose function; however, the complex relationship
between these genes has not been fully elucidated [4, 5].
Therefore, it is important to explore the regulation and
function of key genes involved in adipose function.
Peroxisome proliferator-activated receptor γ (PPARγ)
is a critical gene in the regulation of adipose function.
Studies have shown that PPARγ is involved in several
physiological functions of adipose, including adipocyte
differentiation [6–8], adipokine secretion [9, 10], adipose
tissue inflammation [11] and insulin sensitivity [12].
Therefore, investigating the regulation of PPARγ is im-
portant to further understand adipose function. Twist 1
is a well-conserved transcription factor that belongs to
the basic helix-loop-helix (bHLH) family. Twist 1 has
been shown to be important for the formation of adipose
tissue, and recently, several studies have investigated the
role of Twist 1 in adipose dysfunction. Twist 1 expres-
sion in subcutaneous adipose tissue and visceral adipose
tissue is related to the pathogenesis of several metabolic
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syndromes, including obesity, inflammation and insulin
resistance [13–15]. Therefore, PPARγ and Twist 1 are
two genes with multiple similar functional roles in the
regulation of adipose tissue.
However, it is unclear whether there is an interaction
between Twist 1 and PPARγ in the functional regulation
of adipose tissue. Recent studies have found that the
function of Twist 1 in adipose tissue is closely related to
PPAR family members. Twist 1 has been shown to be a
PPAR delta-inducible, negative-feedback regulator of
PGC-1 in brown fat metabolism, which has important
implications for understanding metabolic control and
metabolic diseases [16]. PPARγ has been shown to
control the Twist 1-SMRT-GPS2 cascade, which is a
regulatory transcriptional network involved in several
functional processes in human adipocytes [17]. Previous
studies from our laboratory also found evidence of Twist
1 and PPARγ regulation in 3T3-L1 preadipocytes. We
showed that the retroviral interference of Twist 1 expres-
sion in 3T3-L1 preadipocytes enhances PPARγ expression
after 4 days of hormone-induced differentiation [18].
These results indicate that the expression of Twist 1 and
PPARγ are regulated by a complex interaction in adipose
tissue. However, further studies are necessary to confirm
the precise mechanism of this interaction.
The aim of this study was to explore whether changes in
Twist 1 level influence PPARγ expression. We used retro-
viral interference and Twist 1 overexpression to determine
the role of Twist 1 on the regulation of PPARγ. Also, we
used a PPARγ inhibitor and agonist to investigate the
effect of PPARγ on Twist 1 expression. We verified that
PPARγ regulates Twist 1 expression. In addition, we
showed that Twist 1 could also influence PPARγ expres-
sion positively. To our knowledge, the effect of Twist 1 on
PPARγ expression is a novel finding. We have enriched
the knowledge of the regulation mechanism of PPARγ,
and these findings may explain the role of Twist 1 in
adipocyte physiology and pathology.
Methods
Reagents
The 3T3-L1 mouse embryo fibroblasts and Dulbecco’s
modified Eagle medium (DMEM) were obtained from
ATCC (Rockefeller, Maryland, USA). Bovine serum and
fetal bovine serum (FBS) were purchased from GIBCO
(Invitrogen, CA, USA). The primary antibodies (anti-
PPARγ and anti-Twist 1) were obtained from Abcam.
The HRP-conjugated secondary antibody and the anti-β-
actin primary antibody were purchased from ZSGB-BIO.
The lentiviral vectors pGLV3/H1/GFP + Puro (LV3), LV4-
EF1a-GFP/Puro (LV5), recombinant vectors LV3/Twist 1
shRNA and LV5/Twist 1 complementary DNA (cDNA)
were all acquired from GenePharma (Shanghai, China).
NE-PER™ Nuclear and Cytoplasmic Extraction Kit was
purchased from Pierce (Thermo Scientific). SYBR® Green
Real-time PCR Master Mix (QPK-201 T) was purchased
from TOYOBO. T0070907 and pioglitazone were both
from Cayman Chemical (MI, USA). Insulin, isobutyl-
methylxanthine, cycloheximide (CHX), leupeptin, pep-
statin A (L/P), proteasomes inhibitors (MG132) and
the other reagents in this study were obtained from
Sigma (Merck, German).
Induction of differentiation and Oil Red O staining in
3T3-L1 preadipocytes
The 3T3-L1 preadipocytes were maintained in DMEM
supplemented with 10 % bovine serum, 100 U/ml of peni-
cillin and 100 mg of streptomycin at 37 °C in a humidified
atmosphere composed of 95 % air and 5 % CO2. The in-
duction of differentiation and the Oil Red O staining were
conducted according to previously described methods [17].
Twist 1 shRNA and Twist 1 cDNA lentiviral vector
construction and packaging
The Twist 1 shRNA and Twist 1 cDNA lentiviral vec-
tors were constructed and packaged by GenePharma.
Twist 1 shRNA was generated based on previously
described methods [17]. The recombinant vector, LV3/
Twist 1 shRNA, and the negative control vector, LV3/
NC, were identified using sequencing. For packaging, a
lentiviral vector titer of 1x109 TU/mL was used in the
infection experiments.
The full Twist 1 cDNA sequence was synthesized using
chemical methods. The Kozak protection sequence
(GCCACC) and a NotI site (GCGGCCGC) were added to
the 5′-end of the Twist 1 cDNA. A BamHI site
(GGATCC) was added to the 3′-end of the Twist 1 cDNA.
This complex was then inserted into the expression vector
LV4-EF1a-GFP/Puro (LV5), which also served as a nega-
tive control in this study. A lentiviral vector titer of 1×109
TU/ml of LV5/Twist 1 cDNA was used in the infection
experiments.
Lentiviral vector infection with LV3/Twist1 shRNA and
LV5/Twist 1 cDNA
Mature adipocytes were infected with the lentiviral vec-
tors (LV3/Twist1 shRNA, LV3/NC, LV5/Twist 1 cDNA
and LV5/NC) 6 d after the induction of differentiation.
The proportion of the lentiviral vector and high-glucose
DMEM supplemented with 10 % FBS was 1:20. The cells
were incubation for 8–12 h, and then, the infection
medium was replaced with culture medium containing
10 % FBS and incubated for 48 h.
Extraction of cytoplasmic and nuclear proteins
Cytoplasmic and nuclear proteins were extracted using a
NE-PER™ Nuclear and Cytoplasmic Extraction Kit (Prod#
78833) according to the manufacturer’s instructions. Briefly,
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the cells were washed three times, harvested with 1 ml of
PBS and centrifuged at 500xg for 5 min in microcentrifuge
tubes. Ice-cold CER I buffer was added to homogenize the
cells, and the homogenate was vigorously vortexed for 15 s
and incubated for 10 min on ice. Next, ice-cold CER II buf-
fer was added, and the mixture was vortexed for 5 s and
incubated for 1 min. The mixture was centrifuged for
5 min at 16,000xg and the supernatant solution was trans-
ferred to a fresh microcentrifuge tube as the cytoplasmic
protein fraction. The remaining pellet was suspended in
ice-cold NER buffer and then vortexed for 40 min with 15-
s breaks every 10 min. Finally, the samples were centrifuged
at 16,000xg for 15 min to obtain the supernatant as the
nuclear fraction.
RNA extraction and real-time PCR detection
Total RNA was extracted using TRIzol (Invitrogen) ac-
cording to conventional experimental procedure, and
cDNA was synthesized based on standard protocols of
RevertAid First Strand cDNA Synthesis kit (Thermo
Scientific). Real-time PCR detection was conducted
using the SYBR® Green Real-Time PCR Master Mix Kit
according to the manufacturer’s instructions. The PCR
primers were designed using Primer 5.0 software, and
the primer sequences has been shown in Table 1. The
relative quantification of the target sequence was deter-
mined as the fold changes compared with GAPDH
mRNA using the 2-ΔΔ Ct method. All reactions were
conducted in triplicate.
Western blot analysis
Western blotting was conducted according to previously
described methods [18]. The membranes were incubated
overnight at 4 °C with primary antibodies for anti-
PPARγ (1:1,000), anti-Twist1 (1:50) and anti-β-actin
(1:2500). The target molecular weights for Twist 1,
PPARγ and β-actin were 21 kDa, 58 kDa and 43 kDa,
respectively. The relative OD ratio was calculated using
ImageJ software and normalized to β-actin. Data from
three replicate experiments were analyzed.
Statistical analyses
For Oil Red O staining, the data are presented as the OD
values. ImageJ software was used to quantify the results
from the western blotting experiment. The relative gray
value of each band was calculated based on results of
three replicates. All data are shown as the mean ± SD, and
the data were analyzed using SPSS software package,
version 17.0. T tests were used for comparisons between
two groups. A one-way analysis of variance (ANOVA) was
performed for comparisons between more than two
groups, and Dixon’s q tests were used for further pairwise
comparisons. P < 0.05 was considered significant.
Results
Twist 1 and PPARγ expression is induced during 3T3-L1
differentiation
Differentiation was induced in 3T3-L1 preadipocytes
according to previously described methods, and obvious
morphological changes were observed during differenti-
ation. As shown in Fig. 1a, the confluent 3T3-L1 preadi-
pocytes exhibited a long shuttle shape without lipid
droplets. During differentiation, a portion of the adipo-
cytes began to accumulate lipids, which spread until
most of the adipocytes were full of lipid droplets at day
8–12 after the initiation of induction. Lipid accumula-
tion was quantified using Oil Red O staining (Fig. 1b),
and significant differences in lipid content were observed
4 d after differentiation (*P < 0.05).
The mRNA and protein expression of Twist 1 and
PPARγ in 3T3-L1 adipocytes were confirmed using real
time PCR and western blotting, respectively. Figure 1c
shows that there were significant increases in the mRNA
levels of Twist 1 and PPARγ in the mature 3T3-L1 adi-
pocytes (*P < 0.05). In addition, Twist 1 and PPARγ pro-
tein expression levels were significantly upregulated in
mature 3T3-L1 adipocytes compared with the 3T3-L1
preadipocytes (Fig. 1d, e, *P < 0.05).
Application of pioglitazone and T0070907 alters Twist 1
expression levels
To determine how PPARγ regulates Twist 1 expression,
we added pioglitazone (1 μM, 24 h), a classic PPARγ agon-
ist, and T0070907 (100 μM, 24 h), a common PPARγ
inhibitor, into the culture medium of 3T3-L1 mature adi-
pocytes and determined the protein expression of Twist 1.
Taken the relative Twist 1 expression in both control
group as 100 %, the expression level of Twist 1 in the
Table 1 Sequence information on the primers used for RT-PCR
Genes Sequences Product size (bp) Annealing temperature (°C) Gene Bank
Mouse Twist 1 5′-CATGGCTAACGTGCGGGA-3′ 124 60 NM_011658.2
5′-CGCCAGTTTGAGGGTCTGAA-3′
Mouse PPARγ 5′-GCTGACCCAATGGTTGCTGA-3′ 181 60.5 NM_001127330.2
5′-CTTTATCCCCACAGACTCGGC-3′
GAPDH 5′-TGGCCTTCCGTGTTCCTAC-3′ 178 59 NM_001289726.1
5′-GAGTTGCTGTTGAAGTCGCA-3′
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pioglitazone (1 μM, 24 h) exposure group was significantly
upregulated (164.3 ± 20.51 %, P < 0.05) (Fig. 2a, b), while
that in the T0070907 (100 μM, 24 h) treatment group was
(30.51 ± 4.62) %, significantly down-regulated (P < 0.05)
(Fig. 2c, d).
Retroviral interference or overexpression of Twist 1
regulates PPARγ expression by targeting protein
synthesis
LV3/Twist1 shRNA (LV3/Twist 1- group) reduced Twist
1 expression to (44.80 ± 7.48) % compared with the con-
trol and LV3/NC group (P < 0.05), which suggest that
retroviral interference was effective. Taken the relative
PPARγ expression in control group as 100 %, the expres-
sion level of PPARγ in the LV3/Twist 1- group was
(57.75 ± 5.66) %, significantly downregulated (P < 0.05)
(Fig. 3a, b). While as shown in Fig. 3c, d, Twist 1 overex-
pression by the lentivirus vector LV4-EF1a-GFP/Puro
(LV5) significantly increased Twist 1 expression to
(158.12 ± 7.23) % in the LV5/Twist 1+ group (P < 0.05).
Correspondingly, PPARγ expression was increased in the
LV5/Twist 1+ group to (141.16 ± 14.55 %, P < 0.05).
Increased protein synthesis or decreased protein degrad-
ation might be responsible for the upregulation of PPARγ
expression observed in our experiments. To confirm which
pathway is involved, we incubated the 3T3-L1 adipocytes
with either a protein synthesis inhibitor (CHX) or
protease inhibitor (L/P) and proteasome inhibitor
(MG132) 1 h before treatment with the LV5/Twist 1+
lentivirus vector. As shown in Fig. 3e, f, CHX abolished
the LV5/Twist 1 + −induced increase in PPARγ expres-
sion (*P < 0.05), while L/P +MG132 application had no
effect on the levels of PPARγ.
PPARγ transcription was confirmed under retroviral
interference or overexpression of Twist 1
Given that Twist 1 regulates PPARγ expression by influen-
cing protein synthesis, we next investigated transcriptional
Fig. 1 The induction of differentiation and the confirmation of Twist 1 and PPARγ expression in 3T3-L1 adipocytes. a The morphological changes
observed in 3T3-L1 preadipocytes during differentiation under bright field and Oil Red O staining. b Quantification of lipids based on Oil Red O
staining. c The transcription levels of Twist 1 and PPARγ were both elevated in adipocytes. d Twist 1 and PPARγ protein expression levels were
upregulated during adipogenesis. e Quantification of the protein expression using ImageJ software
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regulation of PPARγ to confirm this finding. As shown in
Fig. 4a, retroviral interference of Twist 1 (LV3/Twist 1-)
significantly decreased the mRNA expression of PPARγ
transcription (62.2 ± 8.24 %) compared with the control
group (set at 100 %). Twist 1 overexpression signifi-
cantly increased PPARγ mRNA expression (179.53 ±
19.54 %; *P < 0.05) (Fig. 4b).
Discussion
In the present study, we investigated the probable role
of Twist 1 in the regulation of PPARγ expression. We
found PPARγ and Twist 1 were both upregulated during
adipogenesis. Application of pioglitazone increased
Twist 1 expression and T0070907 exposure decreased
Twist 1 expression level. Similarly, retroviral interference
or overexpression of Twist 1 positively regulated PPARγ
levels by influencing protein synthesis. To our know-
ledge, this is the first study to report that Twist 1 regu-
lates PPARγ expression; however, PPARγ control of
Twist 1 expression has been previously reported [17].
We have previously successfully induced mature and
stable differentiation of adipocytes from preadipocytes
[19]. In this study, we observed morphological changes
that indicate adipogenesis (including the appearance of
lipids) from day 4 after the induction of differentiation.
PPARγ regulates adipocyte differentiation, and PPARγ up-
regulation is necessary and sufficient for adipocyte forma-
tion [20]. We detected PPARγ upregulation in adipocytes
during differentiation, which is consistent with previous
reports [17, 18, 21]. In addition, in this study, we showed
that Twist 1 was upregulated during adipogenesis, which
has been confirmed in our previous studies [18]. Overex-
pression of Twist 1 has also been shown to enhance the
capacity of purified human bone marrow-derived mesen-
chymal stromal/stem cells to undergo adipogenesis [22].
Similarly, our results suggest that Twist 1 has a critical
function in adipocyte differentiation. These preliminary
results suggested that maybe there are some cross-
functions for Twist 1 and PPARγ in adipocytes, indicated
the possibility of probable regulation between Twist 1 and
PPARγ. Further studies about the regulatory link between
Twist 1 and PPARγ were necessary and meaningful.
Fig. 2 T0070907 and pioglitazone treatment changed Twist 1
expression. a The effect of pioglitazone (1 μM, 24 h) application on
Twist 1 expression assessed by western blotting. b The relative
quantification of Twist 1 expression after pioglitazone treatment.
c T0070907 treatment (100 μM, 24 h) decreased Twist 1 expression,
as detected by western blotting. d Quantification of the Twist 1
protein expression under T0070907 exposure using ImageJ software
Fig. 3 Retroviral interference or overexpression of Twist 1 positively
regulated PPARγ expression by influencing PPARγ protein synthesis.
a Twist 1 and PPARγ expression after shRNA targeted Twist 1
interference. b Quantification of the protein expression in (a) using
ImageJ software. c Twist 1 and PPARγ expression after the
overexpression of Twist 1 cDNA. d Quantification of the protein
expression in (c) using ImageJ software. e Alterations in PPARγ
protein synthesis and protein degradation after treatment with
either CHX or L/P + MG132. f Quantification of the protein
expression in (e) using ImageJ software
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The PPARγ antagonist T0070907 has been widely used
to inhibit PPARγ activity [23–25]. In this study, we
proved that Twist 1 expression of 3T3-L1 adipocytes
was downregulated under T0070907, which indicates
that PPARγ downregulation inhibits Twist 1 expression.
Several studies have also used the PPARγ agonist pioglit-
azone to investigate the function of PPARγ [26]. The
positive regulation between PPARγ and Twist 1 expres-
sion levels was also observed after pioglitazone treat-
ment in the current study, with obvious up-regulation of
Twist 1 in pioglitazone exposure group. This finding
suggests that PPARγ positively controls Twist 1 expres-
sion. Similarly, studies in diabetic obese patients found
that pioglitazone treatment increased Twist 1 expression
in adipose tissue and showed that PPARγ controlled
Twist 1 expression through the Twist 1-SMRT-GPS2
cascade, which is consistent with our findings [17].
We used retroviral interference or overexpression of
Twist 1 to control Twist 1 expression. The results showed
that Twist 1 downregulation significantly reduced PPARγ
expression. Conversely, Twist 1 overexpression signifi-
cantly increased PPARγ expression. These results indicate
that alterations in Twist 1 expression positively regulate
PPARγ, which has not been shown previously. As an
important member of the bHLH family of transcription
factors, hundreds of genes are regulated by Twist 1,
including miRNAs [27, 28] and genes related to the
epithelial-to-mesenchymal transition (EMT) in carcin-
omas [29, 30]. In addition, Hes4 is a novel bHLH tran-
scription factor that has been shown to be regulated by
Twist 1 and antagonize the function of Twist 1 in regulat-
ing lineage commitment of bone marrow stromal/stem
cells [31]. In this study, we suggest that PPARγ is also
under the regulation of Twist 1.
Two opposite processes may be responsible for the
observed changes in protein expression: protein synthe-
sis and protein degradation. An increase in protein
expression may result from increased protein synthesis
or decreased protein degradation. Therefore, we used
CHX and L/P +MG132 to determine whether the regu-
lation of PPARγ by Twist 1 was a result of changes in
protein synthesis or degradation. Our results confirmed
that the retroviral interference or overexpression of
Twist 1 altered the protein synthesis, and not the protein
degradation, of PPARγ, which was further confirmed by
assessing the transcriptional regulation of PPARγ.
It is worth noting that, there seems to be some dis-
crepancy between the results of our previous report [18]
and the current results for the regulation relationship
between Twist 1 and PPARγ expression. In our previous
work, Twist 1 lentivirus interference increased PPAR
gamma expression in the day 4th differentiation induction
cells, while a downregulation of PPARγ was reported
under Twist 1 lentivirus interference in the current study.
In fact, the research material is quite different between the
present study and the previous work [18], which should
be responsible for the main inconsistence. In our previous
work, we infected Twist 1 interference lentivirus to the
3T3-L1 preadipocytes, and found an increase in PPARγ
expression at day 4th differentiation induction under inter-
ference of Twist 1. However, in the present study, mature
adipocytes were our research objects, and Twist 1 interfer-
ence lentivirus was infected to 3T3-L1 mature adipocytes
after 12–14 days differentiation induction. As we know,
adipogenesis process was a complex process regulated by
multi-genes, adipocytes located in the day 4th differenti-
ation induction was not yet stable, and was a form of tran-
sitional cell phase, which means lots of instability and
complexity. It can’t be excluded that the increase of
PPARγ expression at day 4th differentiation induction may
not be the direct effect of Twist 1. But mature adipocytes
experienced after 12–14 days differentiation induction
were stable, without these above concerns. Further, in the
present study, we introduced Twist 1 overexpression and
PPAR gamma inhibitor to explore the full regulation rela-
tionship between Twist 1 and PPAR gamma, which can
reflect the relationship of both genes from different levels.
In summary, in this study, we reported a possible
regulatory link between Twist 1 and PPARγ, especially
the probable role of Twist 1 in regulating PPARγ expres-
sion. PPARγ has been shown to control the Twist 1-
Fig. 4 PPARγ transcription regulation after retroviral interference or
overexpression of Twist 1. a LV3/Twist 1- treatment reduced the
mRNA expression of PPARγ. b LV5/Twist 1+ treatment increased the
mRNA expression of PPARγ
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SMRT-GPS2 cascade in human adipocytes [17]; however,
our results suggest that an interaction between Twist 1
and PPARγ probably exists in 3T3-L1 adipocytes. This
regulatory link significantly enriched the gene regulation
mechanism of PPARγ and may explain the role of Twist
1 in adipocyte physiology and pathology.
Although not used in this study, a ChIP assay would de-
finitively show the role of Twist 1 in regulating PPARγ.
However, our results provide evidence of a regulatory link
between Twist 1 and PPARγ, which indicate a possible
mechanism of Twist 1 in adipocytes function. Further
studies are necessary to fully elucidate the relationship
between PPARγ and Twist 1 in adipocyte function.
Conclusion
In this study, a possible regulatory link between Twist 1
and PPARγ in 3T3-L1 mature adipocytes was reported.
This regulatory link enriched the regulation mechanism
of PPARγ and may also be critical mechanisms involved
in Twist 1 functions in adipocyte physiology and path-
ology. This study provides theoretical basis for further
studies about the role and mechanism of PPARγ and
Twist 1 in adipocytes.
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